Glycosylation of Human IgA Directly Inhibits Influenza A and Other Sialic-Acid-Binding Viruses

Autor: Lars Hangartner, Larissa Meyer, V. Orlowski, Arkadiusz Wyrzucki, Ngoc Phuong Lan Le, Matteo Bianchi, Hannah L. Turner, Marco Steck, Andrew B. Ward, Max Crispin, Michael A. Maurer
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Immunoglobulin A
Glycosylation
neuraminidase
Chick Embryo
Sialic acid binding
Article
influenza virus
General Biochemistry
Genetics and Molecular Biology

Madin Darby Canine Kidney Cells
Microbiology
03 medical and health sciences
chemistry.chemical_compound
Dogs
0302 clinical medicine
Viral envelope
Chlorocebus aethiops
antibodies
Animals
Humans
innate immunity
Vero Cells
lcsh:QH301-705.5
heterosubtypic antibodies
Innate immune system
biology
Chemistry
Immunity
Innate

N-Acetylneuraminic Acid
3. Good health
Sialic acid
carbohydrates (lipids)
HEK293 Cells
030104 developmental biology
lcsh:Biology (General)
Influenza A virus
virus neutralization
biology.protein
mucosal immunity
Antibody
immunoglobulin
Protein Processing
Post-Translational

Breast feeding
Neuraminidase
IgA
Protein Binding
030215 immunology
Zdroj: Cell Reports, Vol 23, Iss 1, Pp 90-99 (2018)
Cell Reports
ISSN: 2211-1247
Popis: Summary Immunoglobulin A (IgA) plays an important role in protecting our mucosal surfaces from viral infection, in maintaining a balance with the commensal bacterial flora, and in extending maternal immunity via breast feeding. Here, we report an additional innate immune effector function of human IgA molecules in that we demonstrate that the C-terminal tail unique to IgA molecules interferes with cell-surface attachment of influenza A and other enveloped viruses that use sialic acid as a receptor. This antiviral activity is mediated by sialic acid found in the complex N-linked glycans at position 459. Antiviral activity was observed even in the absence of classical antibody binding via the antigen binding sites. Our data, therefore, show that the C-terminal tail of IgA subtypes provides an innate line of defense against viruses that use sialic acid as a receptor and the role of neuraminidases present on these virions.
Graphical Abstract
Highlights • Heterosubtypic IgA1 or IgA2 antibodies neutralize virus much more potently than IgG1 • Sialic acid in IgA’s C-terminal tail competes with viral receptor binding • This may represent an innate line of defense against viral pathogens
Vertebrate IgA molecules possess a conserved N-linked glycosylated C-terminal tail. Maurer et al. show that sialic acid found in the complex glycosylation of the C-terminal tail of human IgA1 inhibits sialic-acid-binding viruses and, therefore, may constitute an additional line of innate immunity.
Databáze: OpenAIRE